New breathing tests to diagnose airway disease in hospital and community settings
Official title: BREATHE: Benchmarking Respiratory Evaluation of Advanced Technologies for Healthcare Excellence
Run by University Hospital Southampton NHS Foundation Trust · NCT07798596 · Data updated 2026-11-12
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University Hospital Southampton NHS Foundation Trust Academic / other |
| Locations | 2 sites (Andover, Hampshire and 1 other locations) |
| Status | Recruiting |
| Started | September 2, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2029 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07798596 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who have a new referral with clinical suspicion of airway disease or COPD and can provide informed consent.
✕Probably not a fit
Patients with confirmed COPD or those unable to tolerate lung function testing may not gain diagnostic advantages from the new tests.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares newer lung tests with standard spirometry to see if they can identify airway disease as accurately, earlier, and more conveniently. It includes adults with suspected COPD or airway disease who are referred to hospital or community services, and collects data on test performance, practicality, and cost. The research will be conducted in clinical settings across multiple NHS sites, with attention to patient comfort and ease of use. No interventions are imposed beyond standard testing plus the additional breathing assessments being evaluated. Results could inform whether simpler, cheaper tests can complement or replace some aspects of current diagnostic pathways.
Why it matters
Potential benefit: If successful, patients could experience earlier, easier, and potentially cheaper COPD diagnosis with less reliance on forceful spirometry.
How similar studies have gone: Previous studies in similar testing approaches suggest potential but require confirmation in real-world NHS settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years of age * New referral to community or secondary healthcare services * Clinical suspicion of airway disease/COPD * Able to provide fully informed written consent * Able to fully understand and cooperate with the study protocol * Clinically stable with no contraindications to lung function testing (outlined below) Exclusion Criteria: * Confirmed diagnosis of COPD * Not willing and/or able to provide fully informed written consent to participate * Has a relative contraindication to lung function testing \[18\]: * Recent thoracic, abdominal or eye (e.g. cataract) surgery \< 6 weeks * Unstable cardiovascular status, including recent myocardial infarction or pulmonary embolus \< 6 weeks * Pneumothorax \< 6 weeks * Haemoptysis of unknown origin \< 6 weeks * Thoracic, abdominal or cerebral aneurysm * Chest infection \< 6 weeks * An acute illness or symptom that might interfere with test performance (e.g. nausea, vomiting). * The presence of any other clinical condition that would prevent the individual from safely performing lung function tests
Where it's running
-
Hampshire Hospitals NHS Foundation Trust
Andover, Hampshire, United Kingdom Recruiting -
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Professor Tom M Wilkinson, MBBS PhD FRCP FERS
- Email: t.wilkinson@soton.ac.uk
- Phone: 02381205341
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
Tele-pulmonary rehab after COPD hospitalization
A tele-rehabilitation program is being tested to see if it helps people with COPD recover after being hospitalized for an acute exacerbation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.